Establishing and reinforcing a drug’s safety profile is essential in today’s safety-conscious world. However, the international nature and sheer volume of patients involved in some trials can create challenges when it comes to tracking and reviewing safety endpoints.
To help overcome these difficulties, Kendle developed TrialEAS™, a Web-based endpoint adjudication system that allows for the review of clinical endpoints without the need of regular meetings and lengthy paper trails. TrialEAS™ streamlines the collection, translation and distribution of endpoint and source documentation, increasing the consistency and quality of our analysis, while reducing costs for your study.
Click here to download our TrialEAS™ factsheet